0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Lack of reaction to ferric gluconate in hemodialysis patients with a history of severe reaction to iron dextran.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Iron deficiency is the most common cause of a poor response to recombinant human erythropoietin (rHuEPO) in patients receiving long-term dialysis, who are known to absorb oral iron preparations poorly. This retrospective case series reports our preliminary observation of five patients receiving long-term dialysis in a tertiary care university hospital who had responded poorly to rHuEPO because of iron deficiency. These patients also had a history of severe, potentially life-threatening reaction to intravenous iron dextran preparation, but they tolerated the newly available ferric gluconate complex in sucrose with no untoward effects. These results suggest that the parenteral administration of ferric gluconate can be safe for those who require iron therapy and who have had a severe reaction to iron dextran.

          Related collections

          Author and article information

          Journal
          ASAIO J.
          ASAIO journal (American Society for Artificial Internal Organs : 1992)
          Ovid Technologies (Wolters Kluwer Health)
          1058-2916
          1058-2916
          July 27 2002
          : 48
          : 4
          Affiliations
          [1 ] Department of Internal Medicine, Saint Louis University School of Medicine, Missouri 63110, USA.
          Article
          10.1097/00002480-200207000-00014
          12141472
          92592fd1-95af-4190-b7f8-00bbfaee2346
          History

          Comments

          Comment on this article